Secondary Main Story

First-in-class Dual HIF Inhibitors Eliminate Multiple Tumor Types in Mice when Combined with Immunotherapy

April 8, 2026

Findings from UMSOP researchers and collaborators point to a promising new strategy for treating a broad range of cancers.

UMSOP Faculty Member Honored with National Baldrige Foundation Leadership Award

April 6, 2026

National recognition highlights Mullins’ leadership in advancing patient-centered health care, health equity, and performance excellence.